Abiopharma

News list

FDA updates labeling for FLONASE ALLERGY RELIEF

FDA Approval
Dec. 31, 2025, 13:45 UTC

Labeling changes approved for HALEON US HOLDINGS. Active ingredient: FLUTICASONE PROPIONATE. Decision date: 12/19/2025

Full text

Register to leave comments
There are no comments here yet...